Updated: Novartis signs macrocyclic deal with Unnatural Productsnews2026-02-18T15:45:20+00:00February 18th, 2026|Endpoints News|
Reversal on Moderna’s flu application follows atypical path through FDAnews2026-02-18T15:45:05+00:00February 18th, 2026|Endpoints News|
Low 2026 EU gas storage to boost spot LNG demandnews2026-02-18T15:45:00+00:00February 18th, 2026|Independent Commodity Intelligence Services (ICIS)|
Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Developmentnews2026-02-18T15:44:00+00:00February 18th, 2026|Medical Device News Magazine|
Hope For The Warriors Awarded $3 Million Grant from Lilly Endowment Inc.news2026-02-18T15:41:43+00:00February 18th, 2026|Medical Device News Magazine|
ProSomnus Secures $38 Million Strategic Investment from Catalio Capital Management to Scale Smart Sleep Medicine™news2026-02-18T15:32:29+00:00February 18th, 2026|Medical Device News Magazine|
Simpson Interventions Announces Initial Series C Close and Rebrands as Elumn8 Medicalnews2026-02-18T15:28:29+00:00February 18th, 2026|Medical Device News Magazine|
Johnson & Johnson Boosts U.S. Presence with $1 Billion+ Investment in Next‑Gen Cell Therapy Facilitynews2026-02-18T15:23:55+00:00February 18th, 2026|Medical Device News Magazine|
ACC Announces Inaugural Fellow for the Thad and Gerry Waites Rural Cardiovascular Research Fellowshipnews2026-02-18T15:17:31+00:00February 18th, 2026|Medical Device News Magazine|
Lilly’s Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido resultsnews2026-02-18T15:16:02+00:00February 18th, 2026|Endpoints News|
